L A Solberg Jr
Overview
Explore the profile of L A Solberg Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Solberg Jr L
Semin Hematol
. 2001 Mar;
38(1 Suppl 2):5-9.
PMID: 11242596
The current dogma about polycythemia vera (PV) is that one or more genetic mutations in a hematopoietic stem cell (HSC) cause abnormal proliferation and differentiation of the progeny of that...
2.
Moreno A, Solberg Jr L
Oncologist
. 2000 Jul;
5(3):238-49.
PMID: 10884502
Purpose: Discrepancies in the quoted prednisone dosages in the regimens reported as the only standard CHOP regimen stimulated our interest in reviewing the medical literature regarding this issue and to...
3.
Solberg Jr L, Tefferi A, Oles K, Tarach J, PETITT R, Forstrom L, et al.
Br J Haematol
. 1997 Nov;
99(1):174-80.
PMID: 9359521
Anagrelide, an inhibitor of platelet aggregation, decreases the number of platelets in normal subjects and in patients with myeloproliferative disorders. We describe studies aimed at discovering the general mechanism(s) by...
4.
Tefferi A, Elliott M, Solberg Jr L, SILVERSTEIN M
Blood Rev
. 1997 Mar;
11(1):1-7.
PMID: 9218101
Among the chronic myeloproliferative disorders, polycythemia vera and essential thrombocythemia are unique because of their association with thrombohemorrhagic manifestations and their relatively indolent clinical course. Patients with essential thrombocythemia may...
5.
Tefferi A, SILVERSTEIN M, PETITT R, Mesa R, Solberg Jr L
Semin Thromb Hemost
. 1997 Jan;
23(4):379-83.
PMID: 9263355
Anagrelide is an oral imidazoquinazoline agent with an anti-cyclic AMP phosphodiesterase activity and inhibits platelet aggregation in both humans and animals. In addition, it has in humans a species-specific platelet-lowering...
6.
Letendre L, Noel P, Tefferi A, Solberg Jr L, Gastineau D, HOAGLAND H
Am J Clin Oncol
. 1995 Oct;
18(5):382-4.
PMID: 7572751
Etoposide (125 mg/m2/d) and carboplatin (200 mg/m2/d) were administered by continuous 5-day intravenous infusion to 10 patients with relapsed or refractory acute leukemia (7 ANLL, 1 ALL, 2 blast crisis...
7.
Gertz M, Pineda A, Chen M, Letendre L, Greipp P, Solberg Jr L, et al.
Am J Med Sci
. 1995 Mar;
309(3):152-61.
PMID: 7879820
Between June 1989 and June 1992, 12 patients with advanced multiple myeloma underwent peripheral blood stem cell autotransplantation after high-dose chemotherapy and radiotherapy. The conditioning regimen included melphalan (140 mg/m2),...
8.
Tefferi A, Colgan J, Solberg Jr L
Mayo Clin Proc
. 1994 Oct;
69(10):991-5.
PMID: 7934198
To summarize recent information about acute porphyrias and to provide clinicians with a practical diagnostic and management approach, we reviewed the pertinent literature and our clinical experience. The acute porphyrias...
9.
Menke D, Greipp P, Solberg Jr L, Cockerill K, Hook C, Witzig T
Arch Pathol Lab Med
. 1994 Aug;
118(8):811-4.
PMID: 7520228
Immunofluorescent staining (immunofluorescence bone marrow aspirate) and immunoperoxidase staining (immunoperoxidase bone marrow biopsy) were compared in 26 patients with plasma cell dyscrasia and less than 10% marrow plasma cells. Their...
10.
Tefferi A, Solberg Jr L, ELLEFSON R
Mayo Clin Proc
. 1994 Mar;
69(3):289-90.
PMID: 8133669
No abstract available.